BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26811407)

  • 1. Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre.
    Witek P; Zieliński G; Szamotulska K; Maksymowicz M; Kamiński G
    Eur J Endocrinol; 2016 Apr; 174(4):539-49. PubMed ID: 26811407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
    De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
    J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MGMT expression in pituitary corticotroph adenomas and its relationship to clinical, pathological, and ultrastructural parameters in patients with Cushing's disease.
    Witek P; Maksymowicz M; Szamotulska K; Piaścik A; Wojciechowska-Luźniak A; Stasiewicz A; Witek J; Zieliński G
    Folia Neuropathol; 2020; 58(4):357-364. PubMed ID: 33480240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
    Wagenmakers MA; Boogaarts HD; Roerink SH; Timmers HJ; Stikkelbroeck NM; Smit JW; van Lindert EJ; Netea-Maier RT; Grotenhuis JA; Hermus AR
    Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
    Woo YS; Isidori AM; Wat WZ; Kaltsas GA; Afshar F; Sabin I; Jenkins PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH adenomas transforming their clinical expression: report of 5 cases.
    Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
    Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing's Disease: Does Size Matter?
    Akirov A; Shimon I; Fleseriu M; Dotan I; Manisterski Y; Aviran-Barak N; Nadler V; Alboim S; Shochat T; Tsvetov G; Hirsch D
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329884
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of clinically silent corticotroph macroadenomas.
    Guttenberg KB; Mayson SE; Sawan C; Kharlip J; Lee JY; Martinez-Lage M; Loevner LA; Ewanichak J; Grady MS; Snyder PJ
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):874-880. PubMed ID: 27346850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corticotroph adenoma].
    Guignat L; Assie G; Bertagna X; Bertherat J
    Presse Med; 2009 Jan; 38(1):125-32. PubMed ID: 19041214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomas.
    Machado MC; Alcantara AE; Pereira AC; Cescato VA; Castro Musolino NR; de Mendonça BB; Bronstein MD; Fragoso MC
    J Endocrinol Invest; 2016 Dec; 39(12):1401-1409. PubMed ID: 27363699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas.
    Cazabat L; Dupuy M; Boulin A; Bernier M; Baussart B; Foubert L; Raffin-Sanson ML; Caron P; Bertherat J; Gaillard S
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):566-72. PubMed ID: 24601912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
    Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
    Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas.
    Losa M; Mortini P; Pagnano A; Detomas M; Cassarino MF; Pecori Giraldi F
    Endocrine; 2019 Feb; 63(2):240-246. PubMed ID: 30315484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
    Rollin G; Ferreira NP; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.